Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation

John M. Park, Constance S. Houck, Navil F. Sethna, Lorna J. Sullivan, Anthony Atala, Joseph G. Borer, Bartley G. Cilento, David A. Diamond, Craig A Peters, Alan B. Retik, Stuart B. Bauer

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

We evaluated the efficacy of ketorolac in suppressing postoperative bladder spasms after ureteroneocystostomy (ureteral reimplantation). Twenty- four pediatric patients undergoing intravesical ureteroneocystostomy were enrolled prospectively to receive either ketorolac or placebo via double- blinded randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1%) with fentanyl (2 μg/mL) throughout the study. Patients were given either ketorolac (0.5 mg · kg-1 · dose-1) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25%) in the ketorolac group experienced bladder spasms, compared with 10 patients (83%) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy.

Original languageEnglish (US)
Pages (from-to)11-15
Number of pages5
JournalAnesthesia and Analgesia
Volume91
Issue number1
DOIs
StatePublished - Jan 1 2000

Fingerprint

Ketorolac
Replantation
Spasm
Urinary Bladder
Pediatrics
Placebos
Bupivacaine
Fentanyl
Random Allocation
Parents

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Park, J. M., Houck, C. S., Sethna, N. F., Sullivan, L. J., Atala, A., Borer, J. G., ... Bauer, S. B. (2000). Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. Anesthesia and Analgesia, 91(1), 11-15. https://doi.org/10.1213/00000539-200007000-00003

Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. / Park, John M.; Houck, Constance S.; Sethna, Navil F.; Sullivan, Lorna J.; Atala, Anthony; Borer, Joseph G.; Cilento, Bartley G.; Diamond, David A.; Peters, Craig A; Retik, Alan B.; Bauer, Stuart B.

In: Anesthesia and Analgesia, Vol. 91, No. 1, 01.01.2000, p. 11-15.

Research output: Contribution to journalArticle

Park, JM, Houck, CS, Sethna, NF, Sullivan, LJ, Atala, A, Borer, JG, Cilento, BG, Diamond, DA, Peters, CA, Retik, AB & Bauer, SB 2000, 'Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation', Anesthesia and Analgesia, vol. 91, no. 1, pp. 11-15. https://doi.org/10.1213/00000539-200007000-00003
Park, John M. ; Houck, Constance S. ; Sethna, Navil F. ; Sullivan, Lorna J. ; Atala, Anthony ; Borer, Joseph G. ; Cilento, Bartley G. ; Diamond, David A. ; Peters, Craig A ; Retik, Alan B. ; Bauer, Stuart B. / Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. In: Anesthesia and Analgesia. 2000 ; Vol. 91, No. 1. pp. 11-15.
@article{69d39eb3fbf941309568823045ea4d51,
title = "Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation",
abstract = "We evaluated the efficacy of ketorolac in suppressing postoperative bladder spasms after ureteroneocystostomy (ureteral reimplantation). Twenty- four pediatric patients undergoing intravesical ureteroneocystostomy were enrolled prospectively to receive either ketorolac or placebo via double- blinded randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1{\%}) with fentanyl (2 μg/mL) throughout the study. Patients were given either ketorolac (0.5 mg · kg-1 · dose-1) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25{\%}) in the ketorolac group experienced bladder spasms, compared with 10 patients (83{\%}) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy.",
author = "Park, {John M.} and Houck, {Constance S.} and Sethna, {Navil F.} and Sullivan, {Lorna J.} and Anthony Atala and Borer, {Joseph G.} and Cilento, {Bartley G.} and Diamond, {David A.} and Peters, {Craig A} and Retik, {Alan B.} and Bauer, {Stuart B.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1213/00000539-200007000-00003",
language = "English (US)",
volume = "91",
pages = "11--15",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation

AU - Park, John M.

AU - Houck, Constance S.

AU - Sethna, Navil F.

AU - Sullivan, Lorna J.

AU - Atala, Anthony

AU - Borer, Joseph G.

AU - Cilento, Bartley G.

AU - Diamond, David A.

AU - Peters, Craig A

AU - Retik, Alan B.

AU - Bauer, Stuart B.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - We evaluated the efficacy of ketorolac in suppressing postoperative bladder spasms after ureteroneocystostomy (ureteral reimplantation). Twenty- four pediatric patients undergoing intravesical ureteroneocystostomy were enrolled prospectively to receive either ketorolac or placebo via double- blinded randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1%) with fentanyl (2 μg/mL) throughout the study. Patients were given either ketorolac (0.5 mg · kg-1 · dose-1) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25%) in the ketorolac group experienced bladder spasms, compared with 10 patients (83%) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy.

AB - We evaluated the efficacy of ketorolac in suppressing postoperative bladder spasms after ureteroneocystostomy (ureteral reimplantation). Twenty- four pediatric patients undergoing intravesical ureteroneocystostomy were enrolled prospectively to receive either ketorolac or placebo via double- blinded randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1%) with fentanyl (2 μg/mL) throughout the study. Patients were given either ketorolac (0.5 mg · kg-1 · dose-1) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25%) in the ketorolac group experienced bladder spasms, compared with 10 patients (83%) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy.

UR - http://www.scopus.com/inward/record.url?scp=0033945788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033945788&partnerID=8YFLogxK

U2 - 10.1213/00000539-200007000-00003

DO - 10.1213/00000539-200007000-00003

M3 - Article

C2 - 10866879

AN - SCOPUS:0033945788

VL - 91

SP - 11

EP - 15

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 1

ER -